Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has B. Paul Morgan's publication output changed over time?
ScholarIQpublication output · 1990–2016
Output grew0% over the shown period — from 1 works in 1990 to 1 in 2016.
1
1
1
1
1
1
1
2
1
1
1990199420012003200620082011201320152016
What are the most-cited papers on B. Paul Morgan?
ScholarIQmost cited works
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Timothy H.J. Goodship, H. Terence Cook, Fádi Fakhouri, Fernando C. Fervenza, Véronique Frémeaux‐Bacchi, David Kavanagh, Carla Nester, Marina Noris, Matthew C. Pickering, Santiago Rodrı́guez de Córdoba, Lubka T. Roumenina, Sanjeev Sethi, Richard J. Smith, Charlie E. Alpers, Gerald B. Appel, Gianluigi Ardissino, Gema Ariceta, Mustafa Arıcı, Arvind Bagga, Ingeborg M. Bajema, Miguel Blasco, Linda Burke, Thomas Cairns, M.C. Carratalá, Vivette D. D’Agati, Mohamed R. Daha, An S. De Vriese, Marie‐Agnès Dragon‐Durey, Agnes B. Fogo, Miriam Galbusera, Daniel P. Gale, Hermann Haller, Sally Johnson, Mihály Józsi, Diana Karpman, Lynne D. Lanning, Moglie Le Quintrec, Christoph Licht, Chantal Loirat, Francisco Monfort, B. Paul Morgan, Laure-Hélène Noël, Michelle M. O’Shaughnessy, Marion Rabant, Éric Rondeau, Piero Ruggenenti, Neil Sheerin, Jenna L.H. Smith, Fabrizio Spoleti, Joshua M. Thurman, Nicole C. A. J. van de Kar, Marina Vivarelli, Peter F. Zipfel
Kidney International. 2016703 CitationsOPEN ACCESS
C3 glomerulopathy: consensus report
Matthew C. Pickering, Vivette D. D’Agati, Carla Nester, Richard J. Smith, Mark Haas, Gerald B. Appel, Charles E. Alpers, Ingeborg M. Bajema, Camille L. Bedrosian, Michael Braun, Mittie K. Doyle, Fádi Fakhouri, Fernando C. Fervenza, Agnes B. Fogo, Véronique Frémeaux‐Bacchi, Daniel P. Gale, Elena Goicoechea de Jorge, Gene Griffin, Claire L. Harris, V. Michael Holers, Sally Johnson, Peter Lavin, Nicholas Medjeral‐Thomas, B. Paul Morgan, Cynthia C. Nast, Laure-Hélène Noël, D K Peters, Santiago Rodrı́guez de Córdoba, Aude Servais, Sanjeev Sethi, Wen-Chao Song, Paul P. Tamburini, Joshua M. Thurman, Michael Zavros, H. Terence Cook
Kidney International. 2013644 CitationsOPEN ACCESS
Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure
Fady I. Malik, James J. Hartman, Kathleen A. Elias, B. Paul Morgan, Héctor M. Rodrı́guez, Katjuša Brejc, Robert L. Anderson, Sandra H. Sueoka, Kenneth Lee, Jeffrey T. Finer, Roman Sakowicz, Ramesh Baliga, David R. Cox, Marc Garard, Guillermo Godinez, Raja Kawas, Erica Kraynack, David Lenzi, Pu Ping Lu, Alexander R. Muci, Congrong Niu, Xiangping Qian, Daniel W. Pierce, Maria Pokrovskii, Ion Suehiro, Sheila Sylvester, Todd Tochimoto, C. Araceli Arellano Valdez, Wenyue Wang, Tatsuo Katori, David A. Kass, You-Tang Shen, Stephen F. Vatner, David J. Morgans
Science. 2011600 Citations
Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
Seppo Meri, B. Paul Morgan, Alun Davies, Robert Daniels, Mark G. Olavesen, Herman Waldmann, P J Lachmann
PubMed. 1990547 CitationsOPEN ACCESS
IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
Maria Isabel Leite, Saiju Jacob, Stuart Viegas, Judy Cossins, Linda Clover, B. Paul Morgan, David Beeson, Nick Willcox, Angela Vincent
Brain. 2008523 CitationsOPEN ACCESS
Related on ScholarIQ
UK Dementia Research Institute
Institution
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Paper
C3 glomerulopathy: consensus report
Paper
Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure
Paper
Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
Paper
IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
Paper